Question Everything. See who's reporting it.

Trump's Tariff Plan Sparks Sharp Drop in Indian Pharma Stocks

Source: Free Press Journal

The story in brief

Indian pharmaceutical stocks fell sharply after Trump announced a phased tariff plan on generic medicines, with Cipla and Dr Reddy’s Laboratories dropping 1.8% and 1.6% on the Nifty 50 index. The plan includes a 100% tariff on imports starting August 1, 2028, and a 200% tariff by 2029, raising concerns over the impact on Indian drugmakers, who supply affordable generics to the US market. The Nifty Pharma index declined 1.51% to 25,699.45.

6 outletsSee what the other 5 outlets said

NEWXFree on Android and iPhone. Open in NEWX